Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Oct 21;64(6):434-439.
doi: 10.1002/jmd2.12397. eCollection 2023 Nov.

Arginase deficiency masked by cerebral palsy and coagulopathy-Three varied presentations of Latin American origin

Affiliations
Case Reports

Arginase deficiency masked by cerebral palsy and coagulopathy-Three varied presentations of Latin American origin

Shelby L Mills et al. JIMD Rep. .

Abstract

Arginase deficiency (ARG1-D) is an autosomal recessive inborn error of metabolism that is often misdiagnosed. Classic presentation of ARG1-D includes progressive symptoms of spasticity, delayed development, cognitive impairment, protein avoidance, and seizures. Patients who present atypically may evade diagnosis and require a thoughtful diagnostic workup. Here, we discuss three females of Latin American origin with differing clinical presentations, but who all have the same intronic pathogenic variant in ARG1. Importantly, we found that each case included elevated coagulopathy on laboratory testing and discussed one case in particular with manifestation of bleeding. When diagnosed early, treatment is favorable and can prevent progressive decline. While many states have added ARG1-D to their expanded newborn screening panels, still many states and countries do not screen for ARG1-D, and it can be missed in a healthy newborn. We aim to bring awareness to not only the classic presentation as a necessary consideration for otherwise unexplained spastic diplegia but also to the varied presentations of ARG1-D.

Keywords: ARG1‐D; arginase deficiency; cerebral palsy; coagulopathy; urea cycle disorders.

PubMed Disclaimer

Conflict of interest statement

Dr. Farach has worked as a consultant for Aeglea BioTherapeutics in the past. Shelby L. Mills, Paige Roberts, Myla Ashfaq, Kathryn Leal, Hope Northrup, Deborah L. Brown, and David Rodriguez‐Buritica declare that they have no conflicts of interest to disclose.

References

    1. Sun A, Crombez EA, Wong D. Arginase deficiency. GeneReviews®. University of Washington; 2020. - PubMed
    1. Morales JA, Sticco KL. Arginase Deficiency. StatPearls. StatPearls Publishing; 2021. - PubMed
    1. Online Mendelian Inheritance in Man . Argininemia . 1986. Retrieved from: https://www.omim.org/entry/207800
    1. Diaz GA, Schulze A, McNutt MC, et al. Clinical effect and safety profile of pegzilarginase in patients with arginase 1 deficiency. J Inher Metabol Dis. 2021;44(4):847‐856. doi:10.1002/jimd.12343 - DOI - PMC - PubMed
    1. Häberle J, Burlina A, Chakrapani A, et al. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. J Inher Metabol Dis. 2019;42(6):1192‐1230. doi:10.1002/jimd.12100 - DOI - PubMed

Publication types

LinkOut - more resources